Management Team
Kamal El Bissati, PhD, CEO
Area of Expertise/Focus: Gene Knockout, Vaccines, Biotechnology, Drug Development
Kamal is a Fulbright US Scholar on medical sciences. He is a microbiologist, with a broad experience leading and managing projects, including preclinical and clinical studies to validate and advance potential new medicines/vaccines and novel diagnostic tools to treat and prevent malaria and toxoplasmosis.
Christopher P. Karch, PhD, CSO
Area of Expertise/Focus: Vaccines, Adjuvants, Immunology, SAPN Expert
Chris is a UConn alumnus (2016) and a Fairfield University (2004) alumnus. He 2018 Maurice R. Hilleman Early-Stage Career Investigator Award winner.
Peter Burkhard, PhD, President
Area of Expertise/Focus: Start-up Companies, Nanotechnology, Biotechnology, Immunology
Peter is the inventor of the SAPN technology and has experience in all aspects developing SAPNs from basic science to GMP production, IND-application and phase I clinical trials. He has also run a start-up company for about 20 years.
